📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Special focus issue on the annual meeting of the British Society for Gene and Cell Therapy. (2015)

First Author: Nicklin SA

Attributed to: Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1089/hum.2015.2500

PubMed Identifier: 25989311

Publication URI: http://europepmc.org/abstract/MED/25989311

Type: Journal Article/Review

Volume: 26

Parent Publication: Human gene therapy

Issue: 5

ISSN: 1043-0342